Real world data of the impact of first cycle daratumumab on multiple myeloma and AL amyloidosis services

Br J Haematol. 2018 Sep;182(6):936-939. doi: 10.1111/bjh.14897. Epub 2017 Aug 18.
No abstract available

Keywords: immunotherapy; monoclonal antibodies; myeloma; myeloma therapy.

Publication types

  • Clinical Trial, Phase II
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Female
  • Hospitalization
  • Humans
  • Immunoglobulin Light-chain Amyloidosis / drug therapy*
  • Infusion Pumps
  • Injection Site Reaction
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Time Factors
  • United Kingdom

Substances

  • Antibodies, Monoclonal
  • daratumumab